Using domperidone to help young people with severe stomach issues
Official title: Compassionate Use of Domperidone for Refractory Gastroparesis
Run by Children's Mercy Hospital Kansas City · NCT04699591 · Data updated 2026-11-12
This study is testing if the medication domperidone can help young people aged 12 to 21 with severe stomach problems that haven't improved with other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 21 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Children's Mercy Hospital Kansas City Academic / other |
| Locations | 1 site (Kansas City, Missouri) |
| Status | Recruiting |
| Started | April 2013 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | March 24, 2026 |
| Trial ID | NCT04699591 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 12 to 21 with severe gastrointestinal symptoms that have not responded to standard therapies.
✕Probably not a fit
Patients who have not been evaluated for other causes of their symptoms or those who are not within the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program allows children aged 12 to 21 with refractory gastroparesis and GERD symptoms to receive domperidone after failing standard treatments. Participants will undergo a thorough medical evaluation, including physical exams and ECGs, to ensure safety before starting the medication. Domperidone will be administered four times daily, with regular follow-ups to monitor health and medication effects. The study aims to provide a potential solution for those suffering from severe gastrointestinal motility disorders.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for young patients suffering from refractory gastroparesis and GERD.
How similar studies have gone: While the use of domperidone has been explored in other contexts, this specific application for refractory gastroparesis in a pediatric population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female 2. Age 12 - 21 3. Symptoms or manifestations secondary to GERD (e.g., persistent esophagitis, heartburn, upper airway signs or symptoms or respiratory symptoms), gastrointestinal motility disorders such as nausea, vomiting, severe dyspepsia or severe chronic constipation that are refractory to standard therapy. 4. Patients must have a comprehensive evaluation to eliminate other causes of their symptoms. 5. Patient has signed informed consent for the administration of domperidone that informs the patient of potential adverse events including: * increased prolactin levels * extrapyramidal side effects * breast changes * Cardiac arrhythmias including QT prolongation * There is a potential for increased risk of adverse events with the drugs and herbal supplements listed in the addendum (See Addendum on pages 24 and 25) * The coordinator/investigator will have a discussion with the family about the use of any of the medications and herbal supplements listed in the addendum to make sure they understand the increased risk of their use and the need to contact the investigators prior to using any of the listed medications and herbal supplements. Exclusion Criteria: 1. History of, or current, arrhythmias including ventricular tachycardia, ventricular fibrillation and Torsade des Pointes. Patients with minor forms of ectopy (PACs) are not necessarily excluded. 2. Clinically significant bradycardia, sinus node dysfunction, or heart block. Prolonged Tc (QTc\> 450 milliseconds for males, QTc\>470 milliseconds for females). 3. Clinically significant electrolyte disorders. 4. Gastrointestinal hemorrhage or obstruction 5. Presence of a prolactinoma (prolactin-releasing pituitary tumor). 6. Pregnant or breast feeding female 7. Known allergy to domperidone
Where it's running
-
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States Recruiting
Study contacts
- Principal investigator: Jose Cocjin, MD — Children's Mercy Hospital Kansas City
- Study coordinator: Corey Schurman, MA, CCRC
- Email: crschurman@cmh.edu
- Phone: 816-302-3076
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gastric-focused ultrasound to see if it changes stomach activity and symptoms
This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.
-
POEM vs Heller myotomy with Dor fundoplication for achalasia
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Thread-Embedding Acupuncture plus a Proton Pump Inhibitor for GERD
This study tests whether adding thread-embedding acupuncture to standard omeprazole treatment helps people with GERD who have a traditional Liver-Stomach constraint-heat pattern.
-
Virtual poetry workshops to boost well-being for people with digestive symptoms
This study tests whether participating in online poetry workshops can improve emotional well-being for adults with chronic digestive symptoms and anxiety or depression.
-
Transoral incisionless fundoplication (TIF) for GERD in Asian adults
This tests whether a less-invasive transoral incisionless fundoplication (TIF) procedure can reduce reflux symptoms in Asian adults who continue to have GERD despite daily PPI treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.